Chagas drug safety in pregnancy under scrutiny in new 10-year study

NCT ID NCT05477953

Not yet recruiting Knowledge-focused Sponsor: Bayer Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times

Summary

This study follows 50 pregnant women with Chagas disease who take or have taken nifurtimox, to see if the drug causes harm to the baby or mother. Researchers will track birth defects, pregnancy outcomes, and infant health up to 12 months old. The goal is to collect safety data, not to treat the disease. Results will be compared to the general population.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHAGAS DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chagas disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHAGAS DISEASE

Contacts and locations

Locations

Many Locations

Multiple Locations, West Virginia, 26505, United States
Many Locations

Multiple Locations, Argentina
Many Locations

Multiple Locations, Bolivia
Many Locations

Multiple Locations, Chile
Many Locations

Multiple Locations, Colombia
Many Locations

Multiple Locations, El Salvador
Many Locations

Multiple Locations, Germany
Many Locations

Multiple Locations, Guatemala
Many Locations

Multiple Locations, Mexico
Many Locations

Multiple Locations, Spain
Many Locations

Multiple Locations, Uruguay
Many locations

Multiple Locations, Honduras

More trials for these conditions

Other studies related to the condition(s) this trial covers.